Epidemiological and etiological variations in hepatocellular carcinoma
- PMID: 31347138
- DOI: 10.1007/s15010-019-01345-y
Epidemiological and etiological variations in hepatocellular carcinoma
Abstract
Background: Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer and a leading cause of cancer-related deaths worldwide. The major risk factors for HCC development are chronic liver disease and cirrhosis due to hepatitis B virus (HBV) and/or hepatitis C virus (HCV), alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), steatohepatitis, intake of aflatoxin-contaminated food, diabetes, and obesity.
Results: In Western countries, the number of NASH-related HCC cases is increasing, that of HBV- or HCV-related cases is declining due to the wide application of HBV universal vaccination and the introduction of effective therapies against HBV and HCV infections, and that of alcohol-related cases remaining substantially unchanged. Nevertheless, the burden of HCC is expected to increase worldwide in the next few decades, due to the population growth and aging expected in coming years. Overall, the abovementioned changes and future variations in lifestyle and in the impact of environmental factors in Western countries and a decreasing exposure to dietary aflatoxins and improved socio-economic conditions in developing countries will create new HCC epidemiology in the next few decades.
Conclusion: A substantial further reduction in cases of HCC requires a wider application of universal HBV vaccination and effective treatment of HBV- and HCV-related chronic hepatitis and cirrhosis, more effective campaigns to favor correct dietary habits and reduce alcohol consumption and the intensification of studies on HCC pathogenesis for future optimized prevention strategies.
Keywords: Alcohol; Epidemiology; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; NAFLD; NASH.
Similar articles
-
The epidemiology and prevention of hepatocellular carcinoma.Semin Oncol. 2001 Oct;28(5):441-9. doi: 10.1016/s0093-7754(01)90137-x. Semin Oncol. 2001. PMID: 11685737 Review.
-
Changing epidemiology of hepatocellular carcinoma in Asia.Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):919-28. doi: 10.1016/j.bpg.2015.09.007. Epub 2015 Sep 10. Best Pract Res Clin Gastroenterol. 2015. PMID: 26651253 Review.
-
Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis.Trop Gastroenterol. 2013 Jul-Sep;34(3):159-63. doi: 10.7869/tg.120. Trop Gastroenterol. 2013. PMID: 24851525
-
Epidemiology of Hepatocellular Carcinoma.Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24. Hepatology. 2021. PMID: 32319693 Free PMC article. Review.
-
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574. Int J Epidemiol. 1998. PMID: 9758109
Cited by
-
4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-α.Clin Transl Med. 2021 Apr;11(4):e379. doi: 10.1002/ctm2.379. Clin Transl Med. 2021. PMID: 33931972 Free PMC article.
-
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis.Cancers (Basel). 2022 Dec 30;15(1):260. doi: 10.3390/cancers15010260. Cancers (Basel). 2022. PMID: 36612256 Free PMC article. Review.
-
Special Issue: "Updates on HBV Infection".Microorganisms. 2022 Mar 7;10(3):580. doi: 10.3390/microorganisms10030580. Microorganisms. 2022. PMID: 35336155 Free PMC article.
-
Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances.Cancers (Basel). 2023 Jan 15;15(2):533. doi: 10.3390/cancers15020533. Cancers (Basel). 2023. PMID: 36672482 Free PMC article. Review.
-
Analysis of Clinical Characteristics of Hepatitis B and Alcohol-Related Liver Cancer.Comput Math Methods Med. 2021 Nov 18;2021:9752534. doi: 10.1155/2021/9752534. eCollection 2021. Comput Math Methods Med. 2021. Retraction in: Comput Math Methods Med. 2023 Mar 9;2023:9848121. doi: 10.1155/2023/9848121. PMID: 34840599 Free PMC article. Retracted.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical